Hawkins, Inc. HWKN has completed the acquisition of the assets of Eagle Labs, Inc., expanding its Water Treatment business into the Dallas–Fort Worth region of Texas. Eagle Labs distributes water treatment products directly to customers in Texas and has in-house manufacturing capabilities.
The acquisition adds two locations in the Dallas–Fort Worth area, increasing Hawkins’ total Water Treatment facilities in Texas to seven. Hawkins first entered the Texas market in fiscal 2022.
According to Hawkins, Eagle Labs brings expertise in coagulants and polymers, along with a customer service model that complements HWKN’s existing Water Treatment operations in the state. Eagle Labs has served North Texas and surrounding areas for more than 30 years, building relationships with local customers and communities.
Hawkins has also opened a new facility in the Dallas–Fort Worth area. The company expects the new facility, together with the acquired Eagle Labs operations, to strengthen its ability to serve water treatment demand across the region.
Price Performance of HWKN
Shares of HWKN are down 30.7% over the past year compared with the industry’s 0.9% decline.
HWKN’s Zacks Rank & Key Picks
HWKN currently carries a Zacks Rank #4 (Sell).
Some better-ranked stocks in the Basic Materials space are Ternium S.A. TX, Avient Corporation AVNT and Innospec Inc. IOSP. TX and AVNT currently sport a Zacks Rank #1 (Strong Buy), while IOSP carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
The Zacks Consensus Estimate for TX’s current-year earnings is $6.54 per share, implying a 201.4% year-over-year increase. Its earnings beat the Zacks Consensus Estimate in two of the trailing four quarters and missed twice, with the negative average surprise being 11.1%.
The Zacks Consensus Estimate for AVNT’s current-year earnings is pegged at $3.2 per share, indicating a 13.5% year-over-year increase. Its earnings beat the Zacks Consensus Estimate in each of the trailing four quarters, with the average surprise being 3.4%.
The Zacks Consensus Estimate for IOSP’s current-year earnings has moved up 3.9% over the past 60 days. Its earnings beat the Zacks Consensus Estimate in each of the trailing four quarters, with the average surprise being 12.9%.
Zacks' Research Chief Names "Stock Most Likely to Double"
Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.
Of course, all our elite picks aren't winners, but this one could far surpass earlier Zacks' Stocks Set to Double like D-Wave Quantum, which shot up +680.1%.
Free: See Our Top Stock And 4 Runners UpWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Hawkins, Inc. (HWKN): Free Stock Analysis Report
Ternium S.A. (TX): Free Stock Analysis Report
Innospec Inc. (IOSP): Free Stock Analysis Report
Avient Corporation (AVNT): Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).